[{"id":"7906adea-ffc6-4844-a4f9-9ece80ef4a3c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05360680","created_at":"2022-05-05T00:56:28.559Z","updated_at":"2024-07-02T16:35:35.573Z","phase":"Phase 1","brief_title":"A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers","source_id_and_acronym":"NCT05360680","lead_sponsor":"Cue Biopharma","biomarkers":" WT1 • CTLA4","pipe":" | ","alterations":" WT1 expression • WT1 positive","tags":["WT1 • CTLA4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e WT1 expression • WT1 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CUE-102"],"overall_status":"Recruiting","enrollment":" Enrollment 52","initiation":"Initiation: 06/14/2022","start_date":" 06/14/2022","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2023-09-27"}]